Atebimetinib
Atebimetinib (IMM-1-104) is an orally active, deeply periodic MEK inhibitor that directly targets MEK and chronically suppresses MAPK signaling. It is intended for combination therapy in metastatic pancreatic cancer and non-small cell lung cancer (NSCLC) .
Product Specifications
CAS Number
2669009-92-9
Field of Research
Signal Transduction
Purity
99.14% (May vary between batches)
Smiles
O=C1OC=2C=C (OC (=O) N (C) C) C=CC2C (=C1CC=3C=CC=C (NS (=O) (=O) NC) C3F) CN (C) C
Molecular Formula
C23H27FN4O6S
Molecular Weight
506.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10442944 96 Well
Rat Low affinity immunoglobulin gamma Fc region receptor II ELISA kit
Sign In for Pricing
View Details 
OR1024283 100 mg
4-Chloro-N- (2- (4-Chlorobenzyl) -3-Oxo-2,3-Dihydro-1,2,4-Thiadiazol-5-Yl) Benzamide
Sign In for Pricing
View Details